1st ANNUAL SCIENTIFIC MEETING OF THE ONE HEALTH EUROPEAN JOINT PROGRAMME ON FOOD-BORNE ZOONOSES, ANTIMICROBIAL RESISTANCE AND EMERGING THREATS
This meeting takes place in Dublin on May 22nd-24th 2019
The conference organising team are delighted to invite you to attend the first Annual Scientific Meeting of the One Health European Joint Programme OHEJP on food-borne zoonoses, antimicrobial resistance and emerging threats. The first One Health EJP Annual Scientific Meeting, is being jointly hosted by Teagasc and NUI Galway and held at the Teagasc Conference Centre, Ashtown, Dublin.
The conference is organised by Dr Geraldine Duffy, Teagasc (Chair) and Dr Dearbháile Morris, National University of Ireland Galway (Co- chair) in collaboration with a local organising team at Teagasc, National University of Galway, Department of Agriculture, Food and the Marine, Food Safety Authority of Ireland, University College Dublin, Health Protection Surveillance Centre and the EJP project management team.
Click on Link: One Health EJP 1st ASM
The UK government has agreed an extra £10 million to fight antimicrobial resistance (AMR) at home and abroad.
•£9 million to the Foundation for Innovative New Diagnostics (FIND)
•£1.5 million funding for a fellowship programme in developing countries to build capacity for calculating and mitigating the economic cost of AMR
•£1 million to an International Reference Centre providing practical support to developing countries to improve their ability to collect data on AMR to better tackle it across human health, animal health, agriculture and the environment
Click to Link: UK Government Funding
European Centre for Disease Prevention and Control (ECDC)
EARS-Net data for 2017 show that antimicrobial resistance remains a serious threat in Europe. For invasive bacterial infections, prompt treatment with effective antimicrobial agents is especially important and is one of the single most effective interventions to reduce the risk of fatal outcome. The high percentages of resistance to key antimicrobial groups reported from many countries are therefore of great concern and represent a serious threat to patient safety in Europe. Prudent antimicrobial use and comprehensive infection prevention and control strategies targeting all healthcare sectors are the cornerstones of effective interventions aiming to prevent selection and transmission of bacteria resistant to antimicrobial agents.
Click to Link: Surveillance of antimicrobial resistance in Europe 2017
As the international community calls for more and better information to add to the ever-growing body of evidence on the effects of antimicrobial resistance (AMR) on humans, animals, the environment and the economy, policy-makers need access to reliable surveillance data. This data is crucial for monitoring the status of key antimicrobial classes (groups of antimicrobials that are related to each other) in the European Region, and to track how effective policies have been in addressing this public health challenge.
The Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAESAR) network complements the surveillance data generated by the European Surveillance of Antimicrobial Resistance Network (EARS-Net) for countries of the European Union and European Economic Area, coordinated by the European Centre for Disease Prevention and Control (ECDC). The latest annual CAESAR report reveals steady progress towards forming a more complete picture of AMR in Europe. The report covers a growing and developing network of 19 countries to date.
Click on Link: CAESAR Report 2018
FEMS Thematic Issue
This Thematic Issue focuses on the effects of anthropogenic use of antibiotics in various ecosystems and the implications for human health. Topics of interest include: evolution of antibiotic resistance, fate and effects of antibiotics in various ecosystems, dissemination of antibiotics and antibiotic resistance genes, bacteria with transferable resistances, co-selection, links between the environment and human health, and mitigation strategies.
Click on Link: FEMS Thematic issue
Change Can’t Wait. Our Time with Antibiotics is Running Out
Each November, World Antibiotic Awareness Week (WAAW) aims to increase global awareness of antibiotic resistance and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of antibiotic resistance.
Since their discovery, antibiotics have served as the cornerstone of modern medicine. However, the persistent overuse and misuse of antibiotics in human and animal health have encouraged the emergence and spread of antibiotic resistance, which occurs when microbes, such as bacteria, become resistant to the drugs used to treat them.
Clink on link: WAAW18
Health & Social Care Select Committee Report website
The UK House of Commons Health & Social Care Select Committee has published a report titled
Eleventh Report of Session 2017–19
Click on Link for report PDF Antimicrobial Resistance Report
The Food and Agriculture Organization of the United Nations has published its 3rd AMR Policy Review and Development Framework
Click on link: Antimicrobial Resistance Policy Review and Development Framework
The WHO World Antibiotic Awareness Week takes place on 12th-18th November 2018. This important event helps to highlight the need to increase the awareness on the use and misuse of antibiotics in the world.
Please publicise this event as widely as possible.
Click link for more information http://www.who.int/campaigns/world-antibiotic-awareness-week/en/
The WHO has just publshed its annual global report on TB
Click on link WHO Global Tuberculosis Report 2018